Skip to Content
UW Health SMPH
American Family Children's Hospital
SHARE TEXT
Justine Y. Bruce, MD close
Justine Y. Bruce, MD

Justine Y. Bruce, MD Print Friendly Page

Faculty, University of Wisconsin School of Medicine and Public Health

Justine Bruce, MD, earned her medical degree at the University of Texas Southwestern Medical School in Dallas and completed her residency at the University of Texas Southwestern Medical School. Dr. Bruce completed a fellowship at the University of Chicago Hospitals and is board certified in internal medicine.

Specialties

Medical Oncology

Palliative Care Medicine

UW Health Clinics

UW Carbone Cancer Center
(608) 265-1700 | (800) 323-8942 | Map
UW Hospital and Clinics
(608) 890-9444 | (800) 323-8942 | Map

Hospital Affiliation(s)

University of Wisconsin Hospital and Clinics (primary)

Languages Spoken

English
Medical interpreters are available to help patients communicate with hospital and clinic staff. For more information, please contact interpreter services at (608) 262-9000.

UW School of Medicine and Public Health

Department of Medicine

Professional Certifications and Education

Board Certification Hospice and Palliative Medicine
Internal Medicine
Medical Oncology
Fellowship University of Chicago Hospitals, Chicago, IL
Residency University of Texas Southwestern Medical Center, Dallas
Internship University of Texas Southwestern Medical Center, Dallas
Medical School University of Texas Southwestern Medical School, Dallas, TX, 2002

PubMed Articles
Hussain M Corn PG Michaelson MD Hammers HJ Alumkal JJ Ryan CJ Bruce JY Moran S Lee SY Lin HM George DJ . Phase II Study of Single-Agent Orteronel (TAK-700) in Patients with Nonmetastatic Castration-Resistant Prostate Cancer and Rising Prostate-Specific Antigen. Clin Cancer Res. 2014 Aug 15;20(16):4218-27
[PubMed ID: 24965748]
Bruce JY Kolesar JM Hammers H Stein MN Carmichael L Eickhoff J Johnston SA Binger KA Heideman JL Perlman SB Jeraj R Liu G . A phase I pharmacodynamic trial of sequential sunitinib with bevacizumab in patients with renal cell carcinoma and other advanced solid malignancies. Cancer Chemother Pharmacol. 2014 Mar;73(3):485-93
[PubMed ID: 24414551]
Bruce JY Lang JM McNeel DG Liu G . Current controversies in the management of biochemical failure in prostate cancer. Clin Adv Hematol Oncol. 2012 Nov;10(11):716-22
[PubMed ID: 23271258]
Bruce JY Eickhoff J Pili R Logan T Carducci M Arnott J Treston A Wilding G Liu G . A phase II study of 2-methoxyestradiol nanocrystal colloidal dispersion alone and in combination with sunitinib malate in patients with metastatic renal cell carcinoma progressing on sunitinib malate. Invest New Drugs. 2012 Apr;30(2):794-802
[PubMed ID: 21174224]